10.08.2020 22:15:00
|
KORU Medical Systems to Present at Canaccord Genuity 40th Annual Growth Conference
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical” or the "Company”) today announced that Don Pettigrew, President and Chief Executive Officer, and Karen Fisher, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020 at 1:00 pm ET.
A live audio webcast and replay will be available on the Investors section of KORU Medical’s website (www.korumedical.com). Please visit KORU Medical’s website approximately 5-10 minutes prior to the presentation to register and download any necessary audio software.
About KORU Medical
KORU Medical manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information about the Company, please visit www.korumedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005707/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Repro Medical System IncShsmehr Nachrichten
12.11.24 |
Ausblick: Repro Medical System stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
29.10.24 |
Erste Schätzungen: Repro Medical System vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
06.08.24 |
Ausblick: Repro Medical System stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
23.07.24 |
Erste Schätzungen: Repro Medical System verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Repro Medical System IncShsmehr Analysen
Aktien in diesem Artikel
Repro Medical System IncShs | 4,07 | 3,04% |